Skip to main content
SpringerLink
Log in

Treatment of Parkinsonism in Patients with Non-Parkinson Dementia

  • Chapter
  • First Online:
Movement Disorders in Dementias

  • 1526 Accesses

Abstract

Parkinsonism and dementia can co-occur in patients without Parkinson’s disease, and most of patients with neurodegenerative parkinsonism develop significant cognitive impairment. Parkinsonism–dementia syndromes notably include dementia with Lewy bodies, progressive supranuclear palsy, corticobasal syndrome, normal-pressure hydrocephalus, vascular parkinsonism and dementia, drug-induced parkinsonism and dementia, frontotemporal lobe dementia, and Alzheimer’s disease. Therapeutic options for parkinsonism in these patients are limited, and data are scarce. In this chapter, we summarize the available information on this topic.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Akiguchi I, Ishii M, Watanabe Y, Watanabe T, Kawasaki T, Yagi H, Shiino A, Shirakashi Y, Kawamoto Y. Shunt-responsive parkinsonism and reversible white matter lesions in patients with idiopathic NPH. J Neurol. 2008;255(9):1392–9.

    Article  PubMed  Google Scholar 

  • Allain H, Bentué-Ferrer D, Tribut O, Mérienne M, Belliard S. Drug therapy of frontotemporal dementia. Hum Psychopharmacol. 2003;18(3):221–5.

    Article  CAS  PubMed  Google Scholar 

  • Aarsland D, Litvan I, Larsen JP. Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson’s disease. J Neuropsychiatry Clin Neurosci. 2001;13:42–9.

    Article  CAS  PubMed  Google Scholar 

  • Birdi S, Rajput AH, Fenton M, Donat JR, Rozdilsky B, Robinson C, et al. Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases. Mov Disord. 2002;17:1255–64.

    Article  PubMed  Google Scholar 

  • Bonelli SB, Ransmayr G, Steffelbauer M, Lukas T, Lampl C, Deibl M. L-dopa responsiveness in dementia with Lewy bodies, Parkinson disease with and without dementia. Neurology. 2004;63:376–8.

    Article  CAS  PubMed  Google Scholar 

  • Burn DJ, Warren NM. Toward future therapies in progressive supranuclear palsy. Mov Disord. 2005;20 Suppl 12:S92–8.

    Article  PubMed  Google Scholar 

  • Burn DJ, Rowan EN, Minett T, Sanders J, Myint P, Richardson J, et al. Extrapyramidal features in Parkinson’s disease with and without dementia and dementia with Lewy-bodies: a cross-sectional comparative study. Mov Disord. 2003;18:884–9.

    Article  PubMed  Google Scholar 

  • Clough CG. A case of normal pressure hydrocephalus presenting as levodopa responsive parkinsonism. J Neurol Neurosurg Psychiatry. 1987;50(2):234.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Czarnecki K, Kumar N, Josephs KA. Parkinsonism and tardive antecollis in frontotemporal dementia–increased sensitivity to newer antipsychotics? Eur J Neurol. 2008;15(2):199–201.

    Article  CAS  PubMed  Google Scholar 

  • Daniele A, Moro E, Bentivoglio AR. Zolpidem in progressive supranuclear palsy. N Engl J Med. 1999;341:543–4; erratum in N Engl J Med. 1999;341:1632.

    Article  CAS  PubMed  Google Scholar 

  • Drach LM. Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia–common features and differences. Med Monatsschr Pharm. 2011;34(2):47–52.

    CAS  PubMed  Google Scholar 

  • Esper CD, Factor SA. Failure of recognition of drug-induced parkinsonism in the elderly. Mov Disord. 2008;23(3):401–4.

    Article  PubMed  Google Scholar 

  • Fahn S, Jankovic J, Hallett M. Atypical parkinsonism, parkinsonism-plus syndromes, and secondary Parkinsonian disorders. In: Fahn S, Jankovic J, Hallett M, editors. Principles and practice of movement disorders. Philadelphia: Churchill Livingstone/Elsevier; 2011. p. 197–240.

    Chapter  Google Scholar 

  • Farooq MU, Moore PW, Bhatt A, Aburashed R, Kassab MY. Therapeutic role of zonisamide in neuropsychiatric disorders. Mini Rev Med Chem. 2008;8:968–75.

    Article  CAS  PubMed  Google Scholar 

  • Fernandez HH, Rodriguez RL, Skidmore FM, Okun MS. A practical approach to any movement disorder: diagnosis, medical and surgical management. New York: Demos Publishing, Inc; 2007.

    Google Scholar 

  • Frank C. Dementia with Lewy bodies. Review of diagnosis and pharmacologic management. Can Fam Physician. 2003;49:1304–11.

    PubMed Central  PubMed  Google Scholar 

  • Giménez-Roldán S, Mateo D, Escalona-Zapata J. Familial Alzheimer’s disease presenting as levodopa-responsive parkinsonism. Adv Neurol. 1987;45:431–6.

    PubMed  Google Scholar 

  • Golbe LI, Sage JI, Duvoisin RC. Drug treatment of 83 patients with progressive supranuclear palsy. Neurology. 1990;40:438.

    Google Scholar 

  • Goldman JG, Goetz CG, Brandabur M, Sanfilippo M, Stebbins GT. Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies. Mov Disord. 2008;23(15):2248–50.

    Article  PubMed  Google Scholar 

  • Graff-Radford NR, Woodruff BK. Frontotemporal dementia. Semin Neurol. 2007;27(1):48–57.

    Article  PubMed  Google Scholar 

  • Imamura T, Takanashi M, Hattori N, et al. Bromocriptine treatment for perseveration in demented patients. Alzheimer Dis Assoc Disord. 1998;12:109–13.

    Article  CAS  PubMed  Google Scholar 

  • Irene L, Yves A, editors. Progressive supranuclear palsy: clinical and research approaches. New York: Oxford University Press; 1992.

    Google Scholar 

  • Jankovic J, Newmark M, Peter P. Parkinsonism and acquired hydrocephalus. Mov Disord. 1986;1:59–64.

    Article  CAS  PubMed  Google Scholar 

  • Kompoliti K, Goetz CG, Litvan I, Jellinger K, Verny M. Pharmacological therapy in progressive supranuclear palsy. Arch Neurol. 1998a;55(8):1099–102.

    Article  CAS  PubMed  Google Scholar 

  • Kompoliti K, Goetz CG, Boeve BF, Maraganore DM, Ahlskog JE, Marsden CD, et al. Clinical presentation and pharmacologic therapy in corticobasal degeneration. Arch Neurol. 1998b;55:957–61.

    Article  CAS  PubMed  Google Scholar 

  • Kurlan R, Richard IH, Papka M, Marshall F. Movement disorders in Alzheimer's disease: more rigidity of definitions needed. Mov Disord. 2000;15:24–9.

    Article  CAS  PubMed  Google Scholar 

  • Liepelt-Scarfone I, Jamour M, Maetzler W. Co-occurrence of parkinsonism and dementia in clinical practice: relevant differential diagnoses. Z Gerontol Geriatr. 2012;45(1):23–33.

    Article  CAS  PubMed  Google Scholar 

  • Lim T, Ahmed A, Itin I, Gostkowski M, Rudolph J, Cooper S, Fernandez HH. Is 6 months of neuroleptic withdrawal sufficient to distinguish drug-induced parkinsonism from Parkinson’s disease? Int J Neurosci. 2013;123(3):170–4.

    Article  CAS  PubMed  Google Scholar 

  • Lubarsky M, Juncos JL. Progressive supranuclear palsy: a current review. Neurologist. 2008;14(2):79–88.

    Article  PubMed  Google Scholar 

  • Lucetti C, Logi C, Del Dotto P, Berti C, Ceravolo R, Baldacci F, Dolciotti C, Gambaccini G, Rossi G, Bonuccelli U. Levodopa response in dementia with Lewy bodies: a 1-year follow-up study. Parkinsonism Relat Disord. 2010;16(8):522–6.

    Article  PubMed  Google Scholar 

  • Mehanna R, Jankovic J. Respiratory problems in neurologic movement disorders. Parkinsonism Relat Disord. 2010;16(10):628–38.

    Article  PubMed  Google Scholar 

  • Mehanna R, Jankovic J. Movement disorders in multiple sclerosis and other demyelinating diseases. J Neurol Sci. 2013a;328(1–2):1–8.

    Article  PubMed  Google Scholar 

  • Mehanna R, Jankovic J. Movement disorders in cerebrovascular disease. Lancet Neurol. 2013b;12(6):597–608.

    Article  PubMed  Google Scholar 

  • Morishita T, Foote KD, Okun MS. INPH and Parkinson disease: differentiation by levodopa response. Nat Rev Neurol. 2010;6(1):52–6.

    Article  CAS  PubMed  Google Scholar 

  • McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47(5):1113–24.

    Article  CAS  PubMed  Google Scholar 

  • McKeith IG, Burn DJ, Ballard CG, Collerton D, Jaros E, Morris CM, et al. Dementia with Lewy bodies. Semin Clin Neuropsychiatry. 2003;8(1):46–57.

    Article  PubMed  Google Scholar 

  • McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, et al., Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65(12):1863–72.

    Google Scholar 

  • Molloy S, McKeith IG, O'Brien JT, Burn DJ. The role of levodopa in the management of dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2005;76(9):1200–3.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Moretti R, Torre P, Antonello RM, Cazzato G, Bava A. Effects of selegiline on frontotemporal dementia: a neuropsychological evaluation. Int J Geriatr Psychiatry. 2002;17:391–2.

    Article  PubMed  Google Scholar 

  • Murata M, Hasegawa K, Kanazawa I, The Japanese Zonisamide on PD Study Group. Zonisamide improves motor function in Parkinson disease: a randomized, doubleblind study. Neurology. 2007;68:45–50.

    Article  CAS  PubMed  Google Scholar 

  • Nieforth KA, Golbe LI. Retrospective study of drug response in 87 patients with progressive supranuclear palsy. Clin Neuropharmacol. 1993;16:338–46.

    Article  CAS  PubMed  Google Scholar 

  • Odawara T, Shiozaki K, Togo T, Hirayasu Y. Administration of zonisamide in three cases of dementia with Lewy bodies. Psychiatry Clin Neurosci. 2010;64(3):327–9.

    Article  PubMed  Google Scholar 

  • Papapetropoulos S, Lieberman A, Gonzalez J, Singer C, Laufer DZ, Mash DC. Family history of dementia: dementia with Lewy bodies and dementia in Parkinson’s disease. J Neuropsychiatry Clin Neurosci. 2006;18(1):113–6.

    Article  PubMed  Google Scholar 

  • Parkinson Study Group. Pramipexole vs. levodopa as initial treatment for Parkinson disease. A randomized controlled trial. JAMA. 2000;84:1931–8.

    Article  Google Scholar 

  • Possin KL, Kaufer DI. Parkinsonian dementias. Continuum. 2010;16(2 Dementia):57–79.

    PubMed  Google Scholar 

  • Poewe W. Treatment of dementia with Lewy bodies and Parkinson's disease dementia. Mov Disord. 2005;20 Suppl 12:S77–82.

    Article  PubMed  Google Scholar 

  • Pujari S, Kharkar S, Metellus P, Shuck J, Williams MA, Rigamonti D. Normal pressure hydrocephalus: long-term outcome after shunt surgery. J Neurol Neurosurg Psychiatry. 2008;79(11):1282–6.

    Article  CAS  PubMed  Google Scholar 

  • Racette BA, Esper GJ, Antenor J, Black KJ, Burkey A, Moerlein SM, et al. Pathophysiology of parkinsonism due to hydrocephalus. J Neurol Neurosurg Psychiatry. 2004;75:1617–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Rahman S, Robbins TW, Sahakian BJ. Comparative cognitive neuropsychological studies of frontal lobe function: implications for therapeutic strategies in frontal variant frontotemporal dementia. Dement Geriatr Cogn Disord. 2001;10 Suppl 1:15–28.

    Article  Google Scholar 

  • Rascol O, Brooks DJ, Korczyn AD, De Deyn PP, Clarke CE, Lang AE. A five-year study of the incidence of dyskinesia in patients with Parkinson’s disease who were treated with ropinirole or levodopa. 056 Study Group. N Engl J Med. 2000;18(342):1481–91.

    Google Scholar 

  • Rabinovici GD, Miller BL. Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS Drugs. 2010;24(5):375–98.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Reed LA, Wszolek ZK, Hutton M. Phenotypic correlations in FTDP-17. Neurobiol Aging. 2001;22:89–107.

    Article  CAS  PubMed  Google Scholar 

  • Sato S, Mizukami K, Asada T. Successful treatment of extrapyramidal and psychotic symptoms with zonisamide in a patient with dementia with Lewy bodies. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(6):1130–1.

    Article  PubMed  Google Scholar 

  • Serrano-Duenas M. Neuroleptic malignant syndrome-like, or—dopaminergic malignant syndrome—due to levodopa therapy withdrawal. Clinical features in 11 patients. Parkinsonism Relat Disord. 2003;9:175–8.

    Article  PubMed  Google Scholar 

  • van Balken I, Litvan I. Current and future treatments in progressive supranuclear palsy. Curr Treat Options Neurol. 2006;8:211–23.

    Article  PubMed  Google Scholar 

  • Vanneste JA. Diagnosis and management of normal-pressure hydrocephalus. J Neurol. 2000;247:5–14.

    Article  CAS  PubMed  Google Scholar 

  • Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA. Parkinsonian like signs and risk of incident Alzheimer disease in older persons. Arch Neurol. 2003;60:539–44.

    Article  PubMed  Google Scholar 

  • Wurtman RJ. Personalized medicine strategies for managing patients with parkinsonism and cognitive deficits. Metabolism. 2013;62 Suppl 1:S27–9.

    Article  CAS  PubMed  Google Scholar 

  • Wszolek ZK, Tsuboi Y, Ghetti B, Pickering-Brown S, Baba Y, Cheshire WP. Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Orphanet J Rare Dis. 2006;1:30.

    Article  PubMed Central  PubMed  Google Scholar 

  • Yoshikawa H, Oda Y, Sakajiri K, Takamori M, Nakanishi I, Makifuchi T, et al. Pure akinesia manifested neuroleptic malignant syndrome: a clinical variant of progressive Supranuclear palsy. Acta Neuropathol. 1997;93:306–9.

    Article  CAS  PubMed  Google Scholar 

  • Zeidler M, Dorman PJ, Ferguson IT, Bateman DE. Parkinsonism associated with obstructive hydrocephalus due to idiopathic aqueductal stenosis. J Neurol Neurosurg Psychiatry. 1998;64(5):657–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Zupancic M, Mahajan A, Handa K. Dementia with Lewy bodies: diagnosis and management for primary care providers. Prim Care Companion CNS Disord. 2011;13(5). pii: PCC.11r01190. doi: 10.4088/PCC.11r01190. PMID:22295275.

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Texas Health Science Center in Houston, Houston, TX, USA

    Raja Mehanna MD

  2. Department of Neurology, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA

    Hubert H. Fernandez MD

Authors
  1. Raja Mehanna MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hubert H. Fernandez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hubert H. Fernandez MD .

Editor information

Editors and Affiliations

  1. Neuroscience Department, Universidad Catolica Argentina, Buenos Aires, Argentina

    Marcelo Merello

  2. Psychiatry and Clinical Neurosciences, University of Western Australia, Fremantle, Australia

    Sergio E. Starkstein

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Mehanna, R., Fernandez, H.H. (2014). Treatment of Parkinsonism in Patients with Non-Parkinson Dementia. In: Merello, M., Starkstein, S. (eds) Movement Disorders in Dementias. Springer, London. https://doi.org/10.1007/978-1-4471-6365-7_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-6365-7_4

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-6364-0

  • Online ISBN: 978-1-4471-6365-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation